Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Current Leases (2019 - 2025)

Ptc Therapeutics has reported Current Leases over the past 7 years, most recently at $3.0 million for Q4 2025.

  • Quarterly results put Current Leases at $3.0 million for Q4 2025, down 71.05% from a year ago — trailing twelve months through Dec 2025 was $3.0 million (down 71.05% YoY), and the annual figure for FY2025 was $3.0 million, down 71.05%.
  • Current Leases for Q4 2025 was $3.0 million at Ptc Therapeutics, up from $2.7 million in the prior quarter.
  • Over the last five years, Current Leases for PTCT hit a ceiling of $14.6 million in Q1 2024 and a floor of $1.7 million in Q1 2021.
  • Median Current Leases over the past 5 years was $3.0 million (2021), compared with a mean of $4.8 million.
  • Biggest five-year swings in Current Leases: skyrocketed 433.22% in 2023 and later tumbled 77.42% in 2024.
  • Ptc Therapeutics' Current Leases stood at $3.0 million in 2021, then changed by 0.0% to $3.0 million in 2022, then changed by 0.0% to $3.0 million in 2023, then soared by 245.43% to $10.4 million in 2024, then tumbled by 71.05% to $3.0 million in 2025.
  • The last three reported values for Current Leases were $3.0 million (Q4 2025), $2.7 million (Q3 2025), and $5.4 million (Q2 2025) per Business Quant data.